The dynamics of FIB4 after sustained viral response predicts the risk of liver-related complication in HCV cirrhosis (ANRS CO12 Cirvir)

被引:0
|
作者
Boursier, Jerome [1 ,2 ]
Nahon, Pierre [3 ]
Guettier, Maxime [1 ]
Moreau, Clemence [1 ]
Riou, Jeremie [4 ]
Audureau, Etienne [5 ]
Roux, Marine [1 ]
机构
[1] Univ Angers, Lab HIFIH, Angers, France
[2] Ctr Hosp Univ, Serv Hepatogastroenterol, Angers, France
[3] Hop Jean Verdier, APHP, Serv Hepatol, Bondy, France
[4] Univ Angers, Lab MINT, Angers, France
[5] Hop Henri Mondor, APHP, Sante Publ, Creteil, France
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AS151
引用
收藏
页码:S104 / S104
页数:1
相关论文
共 12 条
  • [1] VIRAL SUPPRESSION IS NOT A RISK FACTOR FOR CKD IN VIRAL CIRRHOSIS (ANRS CO12 CIRVIR PROSPECTIVE COHORT)
    Bagnis, C. I.
    Layese, R.
    Divard, G.
    Cacoub, P.
    Bourcier, V.
    Corvi, L.
    Petro-Sanchez, V.
    Marcellin, P.
    Guyader, D.
    Pol, S.
    Larrey, D.
    De Ledingen, V.
    Ouzan, D.
    Zoulim, F.
    Deray, G.
    Roudot-Thoraval, F.
    Nahon, P.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S256 - S256
  • [2] EXTRAHEPATIC CANCER IS THE SECOND CAUSE OF NON LIVER-RELATED DEATH IN PATIENTS WITH COMPENSATED VIRAL CIRRHOSIS AND IS ASSOCIATED WITH VIRAL REPLICATION (ANRS CO12 CIRVIR PROSPECTIVE COHORT)
    Allaire, M.
    Bourcier, V.
    Layese, R.
    Corvi, L.
    Petrov-Sanchez, V.
    Marcellin, P.
    Guyader, D.
    Larrey, D.
    De Ledinghen, V.
    Ouzan, D.
    Zoulim, F.
    Roulot, D.
    Tran, A.
    Bronowicki, J. -P.
    Zarski, J. -P.
    Riachi, G.
    Cales, P.
    Peron, J. -M.
    Alric, L.
    Bourliere, M.
    Mathurin, P.
    Nahon, P.
    Roudot-Thoraval, F.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S273 - S273
  • [3] INCIDENCE, CHARACTERISTICS AND DETERMINANTS OF PRIMARY LIVER CANCER OCCURRING DURING SURVEILLANCE OF COMPENSATED HCV CIRRHOSIS ACCORDING TO SUSTAINED VIROLOGICAL RESPONSE (ANRS CO12 CirVir)
    Nahon, P.
    Bourcier, V.
    Layese, R.
    Talmat, N.
    Allam, S.
    Marcellin, P.
    Guyader, D.
    Pol, S.
    Larrey, D.
    Zoulim, F.
    Roulot, D.
    de Ledinghen, V.
    Ouzan, D.
    Zarski, J. -P.
    Trinchet, J. -C.
    Roudot-Thoraval, F.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S432 - S432
  • [4] Benefits of HCV eradication in compensated cirrhotic patients extend beyond liver-related complications: results from the ANRS CO12 CirVir prospective cohort.
    Nahon, Pierre
    Bourcier, Valerie
    Layese, Richard
    Petrov-Sanchez, Ventzislava
    Guyader, Dominique
    Dharancy, Sebastien
    Fontaine, Helene
    Thibault, Vincent
    Leroy, Vincent
    Pol, Stanislas
    Roudot-Thoraval, Francoise
    HEPATOLOGY, 2015, 62 : 1090A - 1090A
  • [5] Mortality and occurrence of liver-related or extra-hepatic complications in patients with HBV- or HCV-related compensated cirrhosis. A multicenter prospective cohort study in 1654 patients (ANRS CO12 CirVir)
    Trinchet, Jean-Claude
    Bourcier, Valerie
    Chaffaut, Cendrine
    Ahmed, Mohand Ait
    Marcellin, Patrick
    Guyader, Dominique
    Pol, Stanislas
    Larrey, Dominique G.
    Zoulim, Fabien
    Roulot, Dominique
    de Ledinghen, Victor
    Ouzan, Denis
    Zarski, Jean-Pierre H.
    Nahon, Pierre
    Chevret, Sylvie
    HEPATOLOGY, 2013, 58 : 1283A - 1283A
  • [6] Aberrant expression of biliary markers by hepatocytes is related to the occurrence of hepatic decompensation and hepatocellular carcinoma in HCV-related cirrhosis (ANRS CO12 CirVir prospective cohort)
    Wendum, Dominique
    Layese, Richard
    Ganne-Carrie, Nathalie
    Bourcier, Valerie
    Merabtene, Fatiha
    Cagnot, Carole
    Sauce, Emmanuel
    Bedossa, Pierre
    Terris, Benoit
    Selves, Janick
    Bioulac-Sage, Paulette
    Sturm, Nathalie
    Sattonnet, Christophe
    Nahon, Pierre
    Roudot-Thoraval, Francoise
    Ziol, Marianne
    HEPATOLOGY, 2016, 64 : 369A - 370A
  • [7] Dynamic personalized prediction of the individual liver-related risk after sustained viral response in HCV patients
    Moreau, Clemence
    Roux, Marine
    Riou, Jeremie
    Canivet, Clemence M.
    Audureau, Etienne
    Lusivika-Nzinga, Clovis
    Nahon, Pierre
    Carrat, Fabrice
    Boursier, Jerome
    JOURNAL OF VIRAL HEPATITIS, 2023, 30 (06) : 567 - 577
  • [8] PRIMARY LIVER CANCER (PLC) IN HCV-RELATED CIRRHOSIS WITH OR WITHOUT HIV COINFECTION. A COLLABORATIVE STUDY BETWEEN TWO FRENCH PROSPECTIVE COHORTS (ANRS CO13 HEPAVIH AND ANRS CO12 CIRVIR)
    Bourcier, Valerie
    Winnock, Maria
    Ahmed, Mohand Ait
    Pambrun, Elodie
    Martin, Isabelle Poizot
    Chevret, Sylvie
    Chaffaut, Cendrine
    Sogni, Philippe
    Trinchet, Jean Claude
    Salmon, Dominique
    HEPATOLOGY, 2009, 50 (04) : 1084A - 1084A
  • [9] Hepatocellular carcinoma (HCC) scoring system for the individualized prediction of liver cancer in 1080 HCV-related compensated cirrhosis included in the French multicenter prospective cohort ANRS CO12 CirVir.
    Ganne, Nathalie
    Bourcier, Valerie
    Layese, Richard
    Talmat, Nabila
    Petrov-Sanchez, Ventzislava
    Marcellin, Patrick
    Guyader, Dominique
    Pol, Stanislas
    Larrey, Dominique G.
    de Ledinghen, Victor
    Ouzan, Denis
    Zoulim, Fabien
    Nahon, Pierre
    Roudot-Thoraval, Francoise
    HEPATOLOGY, 2015, 62 : 1110A - 1110A
  • [10] INCIDENCE AND PREDICTIVE FACTORS OF HEPATOCELLULAR CARCINOMA AND COMPLICATIONS IN HBV- OR HCV-RELATED COMPENSATED CIRRHOSIS. A MULTICENTER PROSPECTIVE COHORT IN 1653 PATIENTS (ANRS CO12 CirVir)
    Trinchet, J. C.
    Bourcier, V.
    Chaffaut, C.
    Ahmed, M. Ait
    Marcellin, P.
    Guyader, D.
    Pol, S.
    Larrey, D.
    Zoulim, F.
    Roulot, D.
    De Ledinghen, V.
    Ouzan, D.
    Zarski, J. P.
    Nahon, P.
    Chevret, S.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S50 - S50